The purpose of the New Product/Application section is to keep you informed
of the latest developments within the laser and other related technologies
field, safety equipment, and related products. ASLMS Members, companies who exhibited at the 2011 ASLMS Annual
Conference and Members of the ASLMS Industry Advisory Council are invited to
post their new products.
The SLIM E30 II MiXto Pro is the successor to the first Micro Fractional CO2 laser the MiXto SX. This fully automated laser features a patented Chopped CW delivery and Z Scanner Algorithm. Safely treats skin types I-VI. Award winning treatment results.
CoolTouch manufacturer of medicallaser devices, announced today ... Their VARIABreeze™ 1064nm laser system has received FDA clearance(K103338) for the temporary increase of clear nail in patients with onychomycosis or toenail fungus. Nail fungus is the cause of yellow, thick, brittle nails. Approximately 36 million people in the U.S. suffer with nail fungus, with 700 million afflicted worldwide. “This FDA clearance is a milestone for CoolTouch, physicians, and patients alike. The CoolBreeze treatment provides clearing of nails without the risks of oral medications and the strict regimen of topical creams” states CoolTouch CEO David Hennings. The CoolBreeze laser procedure itself takes only twenty minutes. Patients begin to see improvement in their nail appearance within weeks. Those treated prefer the laser procedure, as it is safer than oral medications and easier to comply with the topical solutions. The CoolBreeze laser treatment is available at your podiatrist or dermatologist’s office.
Liposonix® is a non-invasive fat reduction system using high intensity focused ultrasound (HIFU) energy to permanently destroy targeted subcutaneous adipose tissue after a single one-hour treatment. The Liposonix® treatment is clinically proven with an average waist circumference reduction of about one inch (one pant or dress size) after 8-12 weeks.
The Apollo system is an advanced solution for wrinkle and rhytides reduction based on TriPollar technology. TriPollar is a 3rd generation radiofrequency technology that has been clinically proven to deliver safe, effective and pain free anti-aging results. Results are visible after the very first treatment.
eTwo combines the unique Sublime and Sublative applications for comprehensive facial rejuvenation: Sublime™ uses the elos combination of IR and Bi-Polar RF to provide controlled deep dermal heating. The unique Sublative™ ergonomic applicator delivers bi-polar radio frequency energy via a matrix of electrodes. This fractional delivery of RF energy causes micro-epidermal ablative injuries with wider spread dermal coagulation.
Disclaimer
The American Society for Laser Medicine and Surgery, Inc. (ASLMS) does not
verify the information provided. The information is provided as is, and
ASLMS disclaims any and all warranties, express or implied, including but
not limited to any warranties of accuracy, reliability, title,
merchantability, non infringement, fitness for a particular purpose, or any
other warranty, condition, guarantee, or representation. The announcement
may have opinions and views of a promotional nature, and do not represent
the opinion of ASLMS. Note that local and state laws vary with regard to who
can use the laser. ASLMS does not promote or endorse any of the products or
services. ASLMS shall not be liable for any direct, indirect, special,
consequential, or punitive damages arising out of your access or inability
to access the New Product/Announcement section. Announcements are accepted
upon the representation that the manufacturer has the right to publish the
contents of the announcement, and that nothing in the announcement infringes
upon any copyright, trade secret, or other intellectual property right. ASLMS reserves the right to reject or cancel any announcement at any time
without cause. Positioning of announcement is at the discretion of ASLMS.
ASLMS shall not be liable for any costs or damages if for any reason it
fails to include an announcement. ASLMS's liability for any error will not
exceed the cost of placement in the Newsletter and on the web site. The
manufacturer agrees to indemnify and hold ASLMS harmless against any expense
or loss by reason of any claims arising out of inclusion in the Newsletter
and web site.
